Literature DB >> 6596459

Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients.

C S Goldstein, J S Bomalaski, R B Zurier, E G Neilson, S D Douglas.   

Abstract

Peritoneal macrophages (PMC) from patients undergoing continuous ambulatory peritoneal dialysis (CAPD) were compared to peritoneal macrophages from healthy volunteers and to peripheral blood monocytes (PBM) from CAPD patients, hemodialysis patients, and healthy volunteers. PMC from CAPD patients had morphology similar to PMC and PBM from healthy volunteers. HLA-DR antigen and Fc receptors were present on the cell surface. These monocytes had similar sequential morphologic changes in long-term culture compared to PBM from healthy volunteers. Phagocytosis, hydrogen peroxide generation and bactericidal activity were the same in PMC from CAPD patients as in PBM from healthy volunteers. Chemotaxis and eicosanoid precursor uptake studies suggest that PMC from CAPD patients may be relatively immature bone-marrow-derived cells. Although these cells function well as phagocytes, further study is warranted to define their immune competence, many components of which develop during differentiation into mature macrophages and may therefore be deficient in patients undergoing CAPD.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6596459     DOI: 10.1038/ki.1984.209

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Usefulness of light microscopic and Cytur test estimation of peritoneal dialysate in early diagnosis of peritonitis.

Authors:  W Sułowicz
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

2.  Difference in the blood monocyte phenotype between uremic patients and healthy controls: its relation to monocyte differentiation into macrophages in the peritoneal cavity.

Authors:  A Brauner; Y Lu; G Halldén; B Hylander; J Lundahl
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

3.  Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis.

Authors:  S Carozzi; M Salit; A Cantaluppi; M G Nasini; S Barocci; S Cantarella; S Lamperi
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

Review 4.  Host defences in continuous ambulatory peritoneal dialysis and the genesis of peritonitis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

5.  Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis.

Authors:  M Chandra; G Clemons; I Sahdev; M McVicar; P Bluestone
Journal:  Pediatr Nephrol       Date:  1993-06       Impact factor: 3.714

6.  The interaction of infant formula with macrophages: effect on phagocytic activity, relationship to expression of class II MHC antigen and survival of orally administered macrophages in the neonatal gut.

Authors:  A Hughes; J H Brock; D M Parrott; F Cockburn
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

7.  Cytokine production by peripheral blood mononuclear cells from pediatric chronic peritoneal dialysis patients.

Authors:  A M Neu; B A Fivush; H M Lederman
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

8.  Human peritoneal mesothelial cells synthesize interleukin-8. Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha.

Authors:  N Topley; Z Brown; A Jörres; J Westwick; M Davies; G A Coles; J D Williams
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

Review 9.  The local inflammatory responses to infection of the peritoneal cavity in humans: their regulation by cytokines, macrophages, and other leukocytes.

Authors:  Marien Willem Johan Adriaan Fieren
Journal:  Mediators Inflamm       Date:  2012-02-26       Impact factor: 4.711

10.  Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation.

Authors:  Justine Bacchetta; Rene F Chun; Barbara Gales; Joshua J Zaritsky; Sandrine Leroy; Katherine Wesseling-Perry; Niels Boregaard; Anjay Rastogi; Isidro B Salusky; Martin Hewison
Journal:  PLoS One       Date:  2014-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.